During the past decade, Midwest Cardiovascular Research Foundation conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 18 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midwest Cardiovascular Research Foundation" #1 sponsor was "C. R. Bard" with 3 trials, followed by "Midwest Cardiovascular Research Foundation" with 3 trials sponsored, "Shockwave Medical, Inc." with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Cardiovascular Systems Inc" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midwest Cardiovascular Research Foundation" #1 collaborator was "Duke Clinical Research Institute" with 3 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator and "Angiodynamics, Inc." with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Midwest Cardiovascular Research Foundation" are "Peripheral Arterial Disease" (8 trials), "Coronary Artery Disease" (5 trials), "Peripheral Artery Disease" (3 trials), "Peripheral Vascular Disease" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Midwest Cardiovascular Research Foundation" in a lesser frequency.

Most popular intervention types in "Midwest Cardiovascular Research Foundation" are "Device" (18 trials), "Drug" (13 trials), "Diagnostic Test" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Tack Endovascular System" (2 trials), "Unfractionated Heparin" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Cardiovascular Research Foundation" are 36 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Midwest Cardiovascular Research Foundation". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 19 completed trials in Midwest Cardiovascular Research Foundation, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Cardiovascular Research Foundation, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".